Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
Verified emails & LinkedIn for founders across this portfolio.
Replimune Group develop the next generation of ‘oncolytic immunotherapies’ for the treatment of cancer.
RumbleON provides an e-commerce platform that facilitates to sell, buy, trade pre-owned recreation vehicles.
SynOx Therapeutics is a biotechnology research company that focused on developing the treatment of diffuse tenosynovial giant cell tumors.
Semperis is a developer of enterprise identity protection and cyber resilience for cross-cloud and hybrid environments.
Electric Hydrogen develops electrolyzer technologies to enable abundant, low-cost, and clean hydrogen to replace fossil fuels.
Kura Oncology, a biopharmaceutical company, advances a pipeline of precision medicines for the treatment of solid tumors and blood cancers.
Better Therapeutics develops prescription software for treating cardiometabolic diseases.
Sight Sciences is a medical device company that uses a computer-based device designed for the treatment of eye disease.
AmplifyBio is a biotechnology company that develops and advances treatments and cures for disease via cutting-edge technology and research.
Provention Bio is a clinical stage biopharmaceutical dedicated to sourcing, developing, and commercializing novel therapeutics.
Oak Street Health is a network of primary care centers for adults on Medicare.
Alladapt Immunotherapeutics is a privately held biopharmaceutical company developing prescription therapeutics targeting food allergy.
ZeroFox provides external cybersecurity solutions to help organizations identify, manage, and mitigate social media-based cyber threats.
Locus Biosciences develops CRISPR-engineered precision antibacterial platform designed to revolutionize the treatment of bacterial disease.
Esme Learning is transforming the world's workforce for the Fourth Industrial Revolution using AI.
Lucira Health is a biotechnology company that offers disposable test kits to detect RNA and DNA of infectious diseases.
NorthSea Therapeutics is a clinical-stage biotech company developing first-in class, oral, structurally-engineered lipid therapeutics.
3GTMS provides transportation management system software for shippers, brokers, and logistics service providers.
Udacity develops an online learning platform offering programs in artificial intelligence, machine learning, and robotics sector.
Hypercore provides a cloud-based platform that manages loan portfolios from origination through repayment.
Dyne Therapeutics is a developer of targeted therapies intended for serious muscle diseases.
Verastem is a biopharmaceutical company developing new medicines to improve the lives of patients with RAS/MAPK pathway-driven cancers.
MoonLake Immunotherapeutics is a clinical-stage biopharmaceuticals company.
X4 Pharmaceuticals is a clinical-stage oncology company developing oral small molecule CXCR4 antagonists for the treatment.
Hercules Capital has invested in 73 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
Hercules Capital's top investment sectors include Biotechnology, Health Care, Therapeutics, Medical, Artificial Intelligence (AI). The firm invests across 45 different industry categories.
Among tracked funding rounds, Dyne Therapeutics received $402.5M in a Post Ipo Equity round. Hercules Capital's total known invested capital is $8.2B.
Hercules Capital's average investment size is $113.0M across its portfolio of 73 companies.
Recent Hercules Capital portfolio additions include Replimune Group, RumbleON, SynOx Therapeutics, Semperis, Electric Hydrogen. These companies were founded in 2020 or later.